TOPOISOMERASE II EXPRESSION IN DRUG RESISTANCE
TOPOISOMERASE II EXPRESSION IN DRUG RESISTANCE
批准号:
2856413
负责人:
SHU-WING NG
金额:
$11.87万
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-01-15 至 2001-12-31
关键词:
CHO cells DNA gyrase antineoplastics binding proteins complementary DNA drug resistance gel mobility shift assay gene expression genetic promoter element genetic regulation genetic transcription isozymes messenger RNA neoplasm /cancer chemotherapy nuclear runoff assay tissue /cell culture transfection
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Type II DNA topoisomerase (topII) is an essential enzyme and is also the
intracellular target for the number of clinically most effective
antineoplastic agents. The intracellular level of top II is an import
determining factor for the cellular sensitivity to top II-targeting
drugs and reduced top II expression is the most commonly observed top
II-mediated drug resistance. Of the two top II isoforms, the 170 kD
form (top IIalpha) is the predominant form to mediate top II functions
and is highly sensitive to top II-targeting agents. Transfection and
overexpression of top IIalpha gene by negative feedback mechanism, which
is important for a strict regulation of the cellular top IIalpha level
and may also contribute to reduced top IIalpha expression in drug
resistance. In addition, one cis-element and its respective binding
activity was identified in the Chinese hamster top IIalpha promoter and
it bears resemblance to a novel inhibitory element in the c-erbB2
promoter. Amplification and overexpression of top IIalpha and c-erbB2
genes have been associated with poor prognosis in breast cancer. Hence,
the study of mechanisms by which top IIalpha is regulated has
significant biological and clinical relevance.
In this proposal, the molecular mechanisms governing the autoregulation
of endogenous top IIalpha expression in EMT6 cells that overexpress CHO
top IIalpha and the reduced top IIalpha expression in two drug resistant
Chinese hamster cell lines will be investigated and compared. The
results will then be used in the study of modulating the top IIalpha
expression in the resistant cell lines and the drug sensitivity of the
cells will be assayed. Based on the high homology between CHO and human
to IIalpha promoters and the conserved regulatory elements and binding
factors, the results of this study are relevant for the study of top II
expression in human cancer and for developing strategies in overcoming
top II-mediated drug resistance in cancer chemotherapy. Elucidating the
mechanisms of regulating tip Iialpha expression is also important in
studying the roles of top II in different cell functions.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Targeting lipid metabolic and signaling enzyme in ovarian cancer
-
批准号:7873528
-
项目类别:
-
资助金额:$21.79万
-
财政年份:2010
-
负责人:SHU-WING NG
-
依托单位:
Targeting lipid metabolic and signaling enzyme in ovarian cancer
-
批准号:8049249
-
项目类别:
-
资助金额:$23.07万
-
财政年份:2010
-
负责人:SHU-WING NG
-
依托单位:
XIST RNA and Ovarian Cancer
-
批准号:6874973
-
项目类别:
-
资助金额:$15.57万
-
财政年份:2004
-
负责人:SHU-WING NG
-
依托单位:
XIST RNA and Ovarian Cancer
-
批准号:6712604
-
项目类别:
-
资助金额:$15.57万
-
财政年份:2004
-
负责人:SHU-WING NG
-
依托单位:
Biomarkers for Ovarian Cancer
-
批准号:6622897
-
项目类别:
-
资助金额:$17.3万
-
财政年份:2002
-
负责人:SHU-WING NG
-
依托单位:
Biomarkers for Ovarian Cancer
-
批准号:6458955
-
项目类别:
-
资助金额:$16.83万
-
财政年份:2002
-
负责人:SHU-WING NG
-
依托单位:
TOPOISOMERASE III AND GENOMIC INSTABILITY
-
批准号:6386613
-
项目类别:
-
资助金额:$25.43万
-
财政年份:2000
-
负责人:SHU-WING NG
-
依托单位:
TOPOISOMERASE III AND GENOMIC INSTABILITY
-
批准号:6130864
-
项目类别:
-
资助金额:$28.15万
-
财政年份:2000
-
负责人:SHU-WING NG
-
依托单位:
TOPOISOMERASE III AND GENOMIC INSTABILITY
-
批准号:6520086
-
项目类别:
-
资助金额:$25.43万
-
财政年份:2000
-
负责人:SHU-WING NG
-
依托单位:
TOPOISOMERASE III AND GENOMIC INSTABILITY
-
批准号:6636344
-
项目类别:
-
资助金额:$25.43万
-
财政年份:2000
-
负责人:SHU-WING NG
-
依托单位:
TOPOISOMERASE II EXPRESSION IN DRUG RESISTANCE
-
批准号:2009539
-
项目类别:
-
资助金额:$5.57万
-
财政年份:1997
-
负责人:SHU-WING NG
-
依托单位:
TOPOISOMERASE II EXPRESSION IN DRUG RESISTANCE
-
批准号:2633924
-
项目类别:
-
资助金额:$6.21万
-
财政年份:1997
-
负责人:SHU-WING NG
-
依托单位:
TOPOISOMERASE II EXPRESSION IN DRUG RESISTANCE
-
批准号:2739730
-
项目类别:
-
资助金额:$11.87万
-
财政年份:1997
-
负责人:SHU-WING NG
-
依托单位:
TOPOISOMERASE II EXPRESSION IN DRUG RESISTANCE
-
批准号:6137566
-
项目类别:
-
资助金额:$11.87万
-
财政年份:1997
-
负责人:SHU-WING NG
-
依托单位:
TOPOISOMERASE II EXPRESSION IN DRUG RESISTANCE
-
批准号:6342005
-
项目类别:
-
资助金额:$11.87万
-
财政年份:1997
-
负责人:SHU-WING NG
-
依托单位:
海外基金